BPTH Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States...

Stats
Dagens volum	41 289.00
Gjennomsnittsvolum	1.47M
Markedsverdi	4.32M
EPS	$0 ( 2024-03-29 )
Neste inntjeningsdato	( $-4.54 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.0220 (0.79%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-02	Cleaver Heath	Buy	10 000	Common Stock Option (right to buy)
2023-05-02	Aubert Paul	Buy	10 000	Common Stock Option (right to buy)
2023-05-02	Sherwood Aline	Buy	10 000	Common Stock Option (right to buy)
2023-05-02	Morris Douglas P	Buy	13 000	Common Stock Option (right to buy)
2023-05-02	Nielsen Peter Henry	Buy	105 000	Common Stock Option (right to buy)

INSIDER POWER
100.00
Last 88 transactions
Buy: 10 429 808 \| Sell: 661 335

Volum Korrelasjon

Lang: -0.09 (neutral)

Kort: -0.43 (neutral)

Signal:(58.676) Neutral

Bio Path Holdings Inc Korrelasjon

10 Mest positive korrelasjoner
BDTX	0.897
PXLW	0.89
IMAB	0.88
SHYF	0.879
FULC	0.876
CPIX	0.874
RMRM	0.873
IVA	0.872
QMCO	0.871
DADA	0.87

10 Mest negative korrelasjoner
LEDS	-0.893
PPBT	-0.881
CINC	-0.87
ASUR	-0.86
SNCR	-0.857
SLGG	-0.851
TSLA	-0.835
MTEK	-0.834
RIBT	-0.827
XOG	-0.823

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bio Path Holdings Inc Korrelasjon - Valuta/Råvare

-0.12
( neutral )

-0.26
( neutral )

0.00
( neutral )

0.05
( neutral )

-0.27
( neutral )

Bio Path Holdings Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-178 000 (0.00 %)
EPS:	$-33.64

FY	2023
Omsetning:	$0
Bruttogevinst:	$-178 000 (0.00 %)
EPS:	$-33.64

FY	2022
Omsetning:	$0
Bruttogevinst:	$-178 000 (0.00 %)
EPS:	$-38.03

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.550

Financial Reports:

No articles found.

Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.